Greiner J W, Evans C H
Cancer Res. 1982 Oct;42(10):4014-7.
The temporal aspects of the anticarcinogenic action of cortisol were investigated by measurement of the frequency of carcinogen-induced morphological transformation of Syrian hamster embryo cells relative to treatment regimen. Treatment of hamster cells with 10(-5) to 10(-11) M cortisol, dexamethasone, corticosterone, 17 beta-estradiol, progesterone, or testosterone did not result in morphological transformation. However, cortisol or dexamethasone treatment beginning 48 hr before the carcinogen caused a dose-dependent reduction in the transformation frequency associated with benzo(a)pyrene [B(a)P] or ultraviolet irradiation treatment. The frequency of B(a)P transformation was reduced 54, 66, and 84% by 10(-11), 10(-10), and 10(-9) M cortisol, respectively, without altering colony formation efficiency. Dexamethasone was equipotent as cortisol as an inhibitor of B(s)P, N-methyl-N'-nitro-N-nitrosoguanidine, or ultraviolet irradiation-induced transformation. Sex steroids, non-steroid antiinflammatory compounds, and steroids without antiinflammatory activity also reduced the transformation frequency but only at concentrations that reduced colony formation. Cortisol inhibition of transformation increased as steroid exposure occurred closer (48, 24, and 8 hr) yet prior to B(a)P treatment. In contrast, if cortisol was added simultaneously with or up to 72 hr after B(a)P, the frequency of transformation was unaffected. Dexamethasone addition after B(a)P, however, reduced the transformation frequency. Thus, physiological concentrations of cortisol when present prior to carcinogen exposure can prevent carcinogen-induced morphological transformation. The ability of cortisol to inhibit ultraviolet irradiation-induced transformation indicates that the anticarcinogenic activity may be mediated by steroid-induced cellular changes which are independent to metabolic activation of the carcinogen.
通过测量相对于处理方案的致癌物诱导的叙利亚仓鼠胚胎细胞形态转化频率,研究了皮质醇抗癌作用的时间方面。用10(-5)至10(-11)M的皮质醇、地塞米松、皮质酮、17β-雌二醇、孕酮或睾酮处理仓鼠细胞,未导致形态转化。然而,在致癌物处理前48小时开始用皮质醇或地塞米松处理,会导致与苯并(a)芘[B(a)P]或紫外线照射处理相关的转化频率呈剂量依赖性降低。10(-11)、10(-10)和10(-9)M的皮质醇分别使B(a)P转化频率降低54%、66%和84%,且不改变集落形成效率。地塞米松作为B(s)P、N-甲基-N'-硝基-N-亚硝基胍或紫外线照射诱导转化的抑制剂,其效力与皮质醇相当。性类固醇、非甾体抗炎化合物和无抗炎活性的类固醇也降低了转化频率,但仅在降低集落形成的浓度下才会如此。随着类固醇暴露时间更接近(48、24和8小时)但在B(a)P处理之前,皮质醇对转化的抑制作用增强。相反,如果在B(a)P处理的同时或之后72小时内添加皮质醇,转化频率不受影响。然而,在B(a)P处理后添加地塞米松会降低转化频率。因此,致癌物暴露前存在的生理浓度的皮质醇可预防致癌物诱导的形态转化。皮质醇抑制紫外线照射诱导转化的能力表明,其抗癌活性可能由类固醇诱导的细胞变化介导,这些变化与致癌物的代谢活化无关。